Clinical Trial: Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915024) titled 'Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants' on Oct. 29.

Brief Summary: This study is a concentration-QTc interval clinical study of HSK31858 tablets in healthy participants.

Study Start Date: Aug. 06

Study Type: INTERVENTIONAL

Condition: Non-cystic Fibrosis Bronchiectasis (NCFBE)

Intervention: DRUG: HSK31858 tablet

oral

DRUG: Placebo

oral

DRUG: Moxifloxacin

oral

Recruitment Status: RECRUITING

Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....